Parkwood LLC’s Trueblue TBI Stock Holding History

Parkwood LLC’s Portfolio TBI Stock Details TBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-324,576	Closed	-$4.06M	–	196
2024 Q1	$4.06M	Buy	+324,576	New	+$4.2M	0.37%	78

Other funds holding TBI

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

ACM

Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Parkwood LLC's TBI Position: Q2 2024 in Review

Parkwood LLC sold out of Trueblue (TBI) in Q2 2024, closing a stake of 324,576 shares — an estimated $4.06M sold.

Parkwood LLC first reported a position in TBI in Q1 2024 and held it in 1 quarter. The position peaked at $4.06M in Q1 2024. 121 funds tracked by Wall St. Rank hold TBI as of Q2 2024.

Parkwood LLC reported no remaining Trueblue position as of Q2 2024 after selling out during the quarter.
Parkwood LLC sold 324,576 Trueblue shares in Q2 2024, an estimated $4.06M.
Parkwood LLC first reported a position in Trueblue in Q1 2024 and held it in 1 quarter.
Parkwood LLC's Trueblue position peaked at $4.06M in Q1 2024.
121 funds tracked by Wall St. Rank held Trueblue as of Q2 2024.

Based on Parkwood LLC's 13F filing for Q2 2024, filed 14 Aug 2024.